These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 17634551)
1. The effect of repeated administration of cyclophosphamide on cytochrome P450 2B in rats. Afsharian P; Terelius Y; Hassan Z; Nilsson C; Lundgren S; Hassan M Clin Cancer Res; 2007 Jul; 13(14):4218-24. PubMed ID: 17634551 [TBL] [Abstract][Full Text] [Related]
2. Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats. Konno Y; Sekimoto M; Nemoto K; Degawa M Toxicol Appl Pharmacol; 2004 Apr; 196(1):20-8. PubMed ID: 15050404 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats. Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294 [TBL] [Abstract][Full Text] [Related]
4. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Agrawal AK; Shapiro BH Mol Pharmacol; 1996 Mar; 49(3):523-31. PubMed ID: 8643092 [TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat. Xie H; Afsharian P; Terelius Y; Mirghani RA; Yasar U; Hagbjörk AL; Lundgren S; Hu Y; Rane A; Hassan M Xenobiotica; 2005 Mar; 35(3):239-51. PubMed ID: 16019949 [TBL] [Abstract][Full Text] [Related]
7. Spatial distribution of CYP2B1/2 messenger RNA within the rat liver acinus following exposure to the inducers phenobarbital and dieldrin. Dail MB; Burgess SC; Meek EC; Wagner J; Baravik J; Chambers JE Toxicol Sci; 2007 Sep; 99(1):35-42. PubMed ID: 17517822 [TBL] [Abstract][Full Text] [Related]
8. Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics. Chen CS; Lin JT; Goss KA; He YA; Halpert JR; Waxman DJ Mol Pharmacol; 2004 May; 65(5):1278-85. PubMed ID: 15102956 [TBL] [Abstract][Full Text] [Related]
9. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats. Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037 [TBL] [Abstract][Full Text] [Related]
10. Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo. Cui X; Thomas A; Han Y; Palamanda J; Montgomery D; White RE; Morrison RA; Cheng KC J Pharmacol Toxicol Methods; 2005; 52(2):234-43. PubMed ID: 16125621 [TBL] [Abstract][Full Text] [Related]
11. Effect of a PCB-based transformer oil on testicular steroidogenesis and xenobiotic-metabolizing enzymes. Andric NL; Kostic TS; Zoric SN; Stanic BD; Andric SA; Kovacevic RZ Reprod Toxicol; 2006 Jul; 22(1):102-10. PubMed ID: 16439096 [TBL] [Abstract][Full Text] [Related]
12. Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides modulate CYP2B1 expression in vivo. Desjardins J; Mata J; Brown T; Graham D; Zon G; Iversen P J Drug Target; 1995; 2(6):477-85. PubMed ID: 7773609 [TBL] [Abstract][Full Text] [Related]
13. Green tea extract increases cyclophosphamide-induced teratogenesis by modulating the expression of cytochrome P-450 mRNA. Park D; Jeon JH; Shin S; Joo SS; Kang DH; Moon SH; Jang MJ; Cho YM; Kim JW; Ji HJ; Ahn B; Oh KW; Kim YB Reprod Toxicol; 2009 Jan; 27(1):79-84. PubMed ID: 19103281 [TBL] [Abstract][Full Text] [Related]
14. Effect of phenytoin on cytochrome P450 2B mRNA expression in primary rat astrocyte cultures. Ibach B; Appel K; Gebicke-Haerter P; Meyer RP; Friedberg T; Knoth R; Volk B J Neurosci Res; 1998 Nov; 54(3):402-11. PubMed ID: 9819145 [TBL] [Abstract][Full Text] [Related]
15. Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitors. Huang Z; Waxman DJ Cancer Gene Ther; 2001 Jun; 8(6):450-8. PubMed ID: 11498765 [TBL] [Abstract][Full Text] [Related]
16. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. Jounaidi Y; Hecht JE; Waxman DJ Cancer Res; 1998 Oct; 58(19):4391-401. PubMed ID: 9766669 [TBL] [Abstract][Full Text] [Related]
17. Suppression of rat hepatic microsomal cytochromes P450 by cyclophosphamide is correlated with plasma thyroid hormone levels and displays differential strain sensitivity. Kraner JC; Morgan ET; Poet TS; Born SL; Burnett VL; Halpert JR J Pharmacol Exp Ther; 1996 Jan; 276(1):258-64. PubMed ID: 8558440 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of cerebral and hepatic cytochrome P450s alters behavioral activity of rat offspring following prenatal exposure to lindane. Johri A; Yadav S; Dhawan A; Parmar D Toxicol Appl Pharmacol; 2007 Dec; 225(3):278-92. PubMed ID: 17919674 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene. Chen L; Yu LJ; Waxman DJ Cancer Res; 1997 Nov; 57(21):4830-7. PubMed ID: 9354446 [TBL] [Abstract][Full Text] [Related]
20. Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm. Wei MX; Tamiya T; Rhee RJ; Breakefield XO; Chiocca EA Clin Cancer Res; 1995 Oct; 1(10):1171-7. PubMed ID: 9815909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]